Cardiff, Wales-based Antiverse's computational platform has been set up to find antibodies against challenging drug targets, ...

BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...

Every time we feel a gentle tap on the skin, specialized nerve cells convert that physical force into an electrical signal the brain can interpret as touch. While scientists have long known that a ...

Antiverse funding, AI antibody discovery, biotech Series A Europe, computational drug discovery, therapeutic antibody design.

Every time we feel a gentle tap on the skin, specialized nerve cells convert that physical force into an electrical signal the brain can ...

Scientists link TMC protein membrane disruption to hearing loss, showing how mutations, drugs and noise trigger hair cell death and deafness.

TD Cowen 46th Annual Health Care Conference March 4, 2026 9:50 AM ESTCompany ParticipantsMartin Hogan - Senior Director ...

OmniAb, Inc. (NASDAQ:OABI) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Good afternoon, and welcome to OmniAb, Inc.’s First — Fourth Quarter 2025 Financial Results and Business Update ...

Antiverse has raised $9.3M in Series A funding to expand its AI driven antibody discovery platform and has entered a research ...

AbCellera Biologics (NASDAQ:ABCL) is positioning itself as a more pipeline-driven biotechnology company after more than a decade of platform investment, according to comments from Senior Director of S ...